Comparative analysis of lymph node metastasesin patients with ypt0-2 rectal cancers after neoadjuvant chemoradiotherapy

Diseases of the Colon and Rectum

Volumn 56, Issue 2, 2013, Pages 135-141

  Park, In Ja ^a   You, Y Nancy ^a   Skibber, John M ^a   Rodriguez Bigas, Miguel A ^a   Feig, Barry ^a   Nguyen, Sa ^a   Hu, Chung Yuan ^a   Chang, George J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemoradiotherapy; Lymph node; Neoadjuvant therapy; Rectal cancer; Treatment response

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREOPERATIVE CARE; RECTUM CANCER; RECTUM RESECTION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; ADJUVANT THERAPY; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIATION DOSE; RECTUM TUMOR; TUMOR RECURRENCE;

AGED; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES;

MLCS; MLOWN;

EID: 84874432736     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e318278ff8a     Document Type: Article

References (33)

1. Hartley A, Ho KF, McConkey C, Geh JI. Pathological completeresponse following pre-operative chemoradiotherapyin rectal cancer: analysis of phase II/III trials. Br J Radiol.2005;78:934-938.
2. Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome inpatients with a pathological complete response after chemoradiationfor rectal cancer: a pooled analysis of individual patientdata. Lancet Oncol. 2010;11:835-844.
3. Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment responseas an early response indicator for patients with rectalcancer. J Clin Oncol. 2012;30:1770-1776.
4. Habr-Gama A, Perez RO, Nadalin W, et al. Operative versusnonoperative treatment for stage 0 distal rectal cancer followingchemoradiation therapy: long-term results. Ann Surg.2004;240:711-717.
5. Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-seepolicy for clinical complete responders after chemoradiationfor rectal cancer. J Clin Oncol. 2011;29:4633-4640.
6. Collette L, Bosset JF, den Dulk M, et al. European Organisationfor Research and Treatment of Cancer Radiation OncologyGroup. Patients with curative resection of cT3-4 rectalcancer after preoperative radiotherapy or radiochemotherapy:does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Researchand Treatment of Cancer Radiation Oncology Group. JClin Oncol. 2007;25:4379-4386.
7. Read TE, Andujar JE, Caushaj PF, et al. Neoadjuvant therapyfor rectal cancer: histologic response of the primary tumor predictsnodal status. Dis Colon Rectum. 2004;47:825-831.
8. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. PolishColorectal Study Group. Prediction of mesorectal nodalmetastases after chemoradiation for rectal cancer: results ofa randomised trial: implication for subsequent local excision.Radiother Oncol. 2005;76:234-240.
9. Hughes R, Glynne-Jones R, Grainger J, et al. Can pathologicalcomplete response in the primary tumour following pre-operativepelvic chemoradiotherapy for T3-T4 rectal cancer predictfor sterilisation of pelvic lymph nodes, a low risk of local recurrenceand the appropriateness of local excision? Int J ColorectalDis. 2006;21:11-17.
10. Pucciarelli S, Capirci C, Emanuele U, et al. Relationship betweenpathologic T-stage and nodal metastasis after preoperativechemoradiotherapy for locally advanced rectal cancer. AnnSurg Oncol. 2005;12:111-116.
11. Perez RO, Habr-Gama A, Proscurshim I, et al. Local excisionfor ypT2 rectal cancer-much ado about something. J GastrointestSurg. 2007;11:1431-1438.
12. Bujko K, Sopylo R, Kepka L. Local excision after radio(chemo)therapy for rectal cancer: is it safe? Clin Oncol (R Coll Radiol).2007;19:693-700.
13. Washington MK, Berlin J, Branton P, et al. Members of theCancer Committee, College of American Pathologists. Protocolfor the examination of specimens from patients with primarycarcinoma of the colon and rectum. Arch Pathol Lab Med.2009;133:1539-1551.
14. Wibe A, Eriksen MT, Syse A, Myrvold HE, Søreide O; NorwegianRectal Cancer Group. Total mesorectal excision for rectalcancer-what can be achieved by a national audit? ColorectalDis. 2003;5:471-477.
15. Heald RJ, Ryall RD. Recurrence and survival after total mesorectalexcision for rectal cancer. Lancet. 1986;1:1479-1482.
16. Bedrosian I, Rodriguez-Bigas MA, Feig B, et al. Predicting thenode-negative mesorectum after preoperative chemoradiationfor locally advanced rectal carcinoma. J Gastrointest Surg.2004;8:56-62.
17. Hiotis SP, Weber SM, Cohen AM, et al. Assessing the predictivevalue of clinical complete response to neoadjuvant therapyfor rectal cancer: an analysis of 488 patients. J Am Coll Surg.2002;194:131-135.
18. Garcia-Aguilar J, Shi Q, Thomas CR Jr, et al. A phase II trial ofneoadjuvant chemoradiation and local excision for T2N0 rectalcancer: preliminary results of the ACOSOG Z6041 trial. AnnSurg Oncol. 2012;19:384-391.
19. Smith FM, Chang KH, Sheahan K, Hyland J, O'Connell PR,Winter DC. The surgical significance of residual mucosal abnormalitiesin rectal cancer following neoadjuvant chemoradiotherapy.Br J Surg. 2012;99:993-1001.
20. Gollub MJ, Gultekin DH, Akin O, et al. Dynamic contrastenhanced-MRI for the detection of pathological complete responseto neoadjuvant chemotherapy for locally advanced rectalcancer. Eur Radiol. 2012;22:821-831.
21. Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal cancer:assessment of complete response to preoperative combinedradiation therapy with chemotherapy-conventional MRvolumetry versus diffusion-weighted MR imaging. Radiology.2011;260:734-743.
22. Vliegen RF, Beets-Tan RG, Vanhauten B, et al. Can an FDGPET/CT predict tumor clearance of the mesorectal fascia afterpreoperative chemoradiation of locally advanced rectal cancer?Strahlenther Onkol. 2008;184:457-464.
23. L eibold T, Akhurst TJ, Chessin DB, et al. Evaluation of 18FFDG-PET for early detection of suboptimal response of rectalcancer to preoperative chemoradiotherapy: a prospectiveanalysis. Ann Surg Oncol. 2011;18:2783-2789.
24. Chang GJ, You YN, Park IJ, et al. Pretreatment high-resolutionrectal MRI and treatment response to neoadjuvant chemoradiation.Dis Colon Rectum. 2012;55:371-377.
25. Guillem JG, Díaz-González JA, Minsky BD, et al. cT3N0 rectalcancer: potential overtreatment with preoperative chemoradiotherapyis warranted. J Clin Oncol. 2008;26:368-373.
26. Yeo SG, Kim DY, Kim TH, et al. Pathologic complete responseof primary tumor following preoperative chemoradiotherapyfor locally advanced rectal cancer: long-term outcomes andprognostic significance of pathologic nodal status (KROG 09-01). Ann Surg. 2010;252:998-1004.
27. Callender GG, Das P, Rodriguez-Bigas MA, et al. Local excisionafter preoperative chemoradiation results in an equivalent outcometo total mesorectal excision in selected patients with T3rectal cancer. Ann Surg Oncol. 2010;17:441-447.
28. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM. Lymphnode status after neoadjuvant radiotherapy for rectal cancer isa biologic predictor of outcome. Cancer. 2009;115:5432-5440.
29. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and Nstage and treatment on survival and relapse in adjuvant rectalcancer: a pooled analysis. J Clin Oncol. 2004;22:1785-1796.
30. Peeters KC, Marijnen CA, Nagtegaal ID, et al. Dutch ColorectalCancer Group. The TME trial after a median follow-up of6 years: increased local control but no survival benefit in irradiatedpatients with resectable rectal carcinoma. Ann Surg.2007;246:693-701.
31. Friel CM, Cromwell JW, Marra C, Madoff RD, Rothenberger DA,Garcia-Aguílar J. Salvage radical surgery after failed local excisionfor early rectal cancer. Dis Colon Rectum. 2002;45:875-879.
32. Lambregts DM, Maas M, Bakers FC, et al. Long-term follow-upfeatures on rectal MRI during a wait-and-see approach after aclinical complete response in patients with rectal cancer treatedwith chemoradiotherapy. Dis Colon Rectum. 2011;54:1521-1528.
33. Garcia-Aguilar J, Chen Z, Smith DD, et al. Identificationof a biomarker profile associated with resistance to neoadjuvantchemoradiation therapy in rectal cancer. Ann Surg.2011;254:486-492.